Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party
- Marie Thérèse Rubio*
- , Maud D’Aveni-Piney
- , Myriam Labopin
- , Rose Marie Hamladji
- , Miguel A. Sanz
- , Didier Blaise
- , Hakan Ozdogu
- , Etienne Daguindeau
- , Carlos Richard
- , Stella Santarone
- , Giuseppe Irrera
- , Ibrahim Yakoub-Agha
- , Moshe Yeshurun
- , Jose L. Diez-Martin
- , Mohamad Mohty
- , Bipin N. Savani
- , Arnon Nagler
*Corresponding author for this work
- Hôpital d'adultes de Brabois
- CNRS UMR 7365
- Université de Lorraine
- Sorbonne Université
- Université Pierre et Marie Curie
- University of Algiers Benyoucef Benkhedda
- Hospital Universitario La Fe
- Institut Paoli Calmettes
- Baskent University
- Hôpital Jean Minjoz
- Hospital Universitario Marques de Valdecilla
- Ospedale Civile
- Azienda Ospedaliera
- CHU de Lille
- Rabin Medical Center Israel
- Hospital General Universitario Gregorio Marañon
- Vanderbilt University
- Sheba Medical Center at Tel Hashomer
Research output: Contribution to journal › Article › peer-review
36
Scopus
citations